Board of Directors

Board of Directors

aTyr’s board of directors plays an important role in guiding the enormous potential of our science through the realities of running a biotech business. Each member has an accomplished track record in biologics and building biotechs from a strong, novel scientific foundation and in navigating and supporting meaningful partnerships and product opportunities.

  • Srini Akkaraju PH.D. »

  • James C. Blair PH.D. »

  • John K. Clarke »

  • Timothy P. Coughlin »

  • Mark Goldberg »

    • Jeffrey S. Hatfield »

    • John D. Mendlein, PH.D. »

      • Amir Nashat PH.D. »

      • Paul Schimmel Ph.D. »

        • Sanjay S. Shukla M.D., M.S. »

          © 2007 - 2018   aTyr Pharma.   Legal   Privacy Policy